B
Catalyst Pharmaceuticals, Inc. CPRX
$21.02 $0.150.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 55.94M 43.88M 40.79M 23.28M 34.84M
Total Depreciation and Amortization 9.46M 9.45M 9.44M 9.43M 9.14M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.04M -6.93M 5.26M 7.87M 4.01M
Change in Net Operating Assets 4.45M 26.47M 8.65M -8.65M 7.65M
Cash from Operations 70.88M 72.87M 64.14M 31.93M 55.65M
Capital Expenditure -88.00K -259.00K -10.00K -199.00K -36.09M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- -2.23M
Cash from Investing -88.00K -259.00K -10.00K -199.00K -38.32M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 5.98M 3.98M 2.03M 142.52M 693.00K
Repurchase of Common Stock -464.00K 0.00 0.00 -204.00K -453.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -1.09M -9.95M -874.00K -1.27M -905.00K
Cash from Financing 4.43M -5.97M 1.16M 141.05M -665.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 75.22M 66.64M 65.28M 172.78M 16.67M
Weiss Ratings